An ethical analysis of obesity as a contraindication to pediatric liver transplant candidacy

Am J Transplant. 2023 Jun;23(6):736-743. doi: 10.1016/j.ajt.2023.03.017. Epub 2023 Mar 29.

Abstract

Childhood obesity is becoming more prevalent in the United States (US) and worldwide, including among children in need of a liver transplant. Unlike with heart and kidney failure, end-stage liver disease (ESLD) is unique in that no widely available medical technology can re-create the life-sustaining function of a failing liver. Therefore, delaying a life-saving liver transplant for weight loss, for example, is much harder, if not impossible for many pediatric patients, especially those with acute liver failure. For adults in the United States, guidelines consider obesity a contraindication to liver transplant. Although formal guidelines are lacking in children, many pediatric transplant centers also consider obesity a contraindication to a pediatric liver transplant. Variations in practice among pediatric institutions may result in biased and ad hoc decisions that worsen healthcare inequities. In this article, we define and report the prevalence of childhood obesity among children with ESLD, review existing guidelines for liver transplant in adults with obesity, examine pediatric liver transplant outcomes, and discuss the ethical considerations of using obesity as a contraindication to pediatric liver transplant informed by the principles of utility, justice, and respect for persons.

Keywords: bias; ethics; health disparities; obesity; pediatric liver transplant.

MeSH terms

  • Adult
  • Child
  • Contraindications
  • End Stage Liver Disease* / complications
  • End Stage Liver Disease* / surgery
  • Ethical Analysis
  • Humans
  • Liver Transplantation* / methods
  • Pediatric Obesity* / surgery
  • United States / epidemiology